Bone microenvironment-related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC-3 prostate cancer cells. - Tenta,R.; Tiblalexi,D.; Sotiriou,E.; Lembessis,P.; Manoussakis,M.; Koutsilieris,M. (Prostate, 2004)